New drug shows promise for managing mixed dyslipidemia
NCT ID NCT04998201
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 26 times
Summary
This study tested an experimental drug called plozasiran in 353 adults with mixed dyslipidemia, a condition with high triglycerides and cholesterol. Participants received either the drug or a placebo for 48 weeks while staying on a heart-healthy diet. The goal was to see if plozasiran safely lowers fat levels in the blood, which could help control long-term heart disease risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Fort Lauderdale, Florida, 33308, United States
-
Research Site 10
Montreal, Quebec, H2W2T2, Canada
-
Research Site 11
Auckland, 2025, New Zealand
-
Research Site 12
Dayton, Ohio, 45419, United States
-
Research Site 13
San Antonio, Texas, 78249, United States
-
Research Site 14
Miami Springs, Florida, 33166, United States
-
Research Site 15
Concord, Ontario, L4K 4M2, Canada
-
Research Site 16
Christchurch, 8013, New Zealand
-
Research Site 17
New Windsor, New York, 12553, United States
-
Research Site 18
Dunwoody, Georgia, 30338, United States
-
Research Site 19
Clayton, Victoria, 3168, Australia
-
Research Site 2
Boca Raton, Florida, 33434, United States
-
Research Site 20
Balatonfüred, H-8230, Hungary
-
Research Site 21
Debrecen, H-4032, Hungary
-
Research Site 22
Nyíregyháza, H-4405, Hungary
-
Research Site 24
Lodz, 94-048, Poland
-
Research Site 25
Poznan, 61-655, Poland
-
Research Site 26
Rzeszów, 35-055, Poland
-
Research Site 27
Joondalup, Western Australia, 6027, Australia
-
Research Site 28
Lodz, 93-338, Poland
-
Research Site 29
Adelaide, South Australia, 5000, Australia
-
Research Site 3
Beverly Hills, California, 90211, United States
-
Research Site 30
Morayfield, Queensland, 4506, Australia
-
Research Site 31
Las Vegas, Nevada, 89121, United States
-
Research Site 32
Houston, Texas, 77030, United States
-
Research Site 4
Franklin, Ohio, 45005, United States
-
Research Site 5
Pembroke Pines, Florida, 33024, United States
-
Research Site 6
Houston, Texas, 77002, United States
-
Research Site 7
Greenville, South Carolina, 29607, United States
-
Research Site 8
Northridge, California, 91325, United States
Conditions
Explore the condition pages connected to this study.